The American Journal of Medicine
Volume 121, Issue 5 , Pages 399-405, May 2008

New Definition of Myocardial Infarction: Impact on Long-term Mortality

  • Willibald Hochholzer, MD

      Affiliations

    • Herz-Zentrum, Bad Krozingen, Germany
    • Both authors have contributed equally and should therefore be considered first author.
  • ,
  • Heinz J. Buettner, MD

      Affiliations

    • Herz-Zentrum, Bad Krozingen, Germany
    • Both authors have contributed equally and should therefore be considered first author.
  • ,
  • Dietmar Trenk, PhD

      Affiliations

    • Herz-Zentrum, Bad Krozingen, Germany
  • ,
  • Kirsten Laule, BSc

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Basel, Switzerland.
  • ,
  • Michael Christ, MD

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Basel, Switzerland.
  • ,
  • Franz-Josef Neumann, MD

      Affiliations

    • Herz-Zentrum, Bad Krozingen, Germany
  • ,
  • Christian Mueller, MD

      Affiliations

    • Herz-Zentrum, Bad Krozingen, Germany
    • Department of Internal Medicine, University Hospital Basel, Basel, Switzerland.
    • Corresponding Author InformationRequests for reprints should be addressed to Christian Mueller, MD, Department of Medicine, University Hospital Basel, Petersgraben 4, Basel CH-4031, Switzerland.

Abstract 

Background

The use of cardiac troponin allows the identification of additional patients developing myocardial necrosis during an acute coronary syndrome. Novel guidelines of European and American cardiac societies recommend labeling these events as myocardial infarction. Our study evaluated the long-term mortality in the group of patients with non-ST segment elevation myocardial infarction not meeting the older World Health Organization (WHO) criteria (creatine phosphokinase) but additionally identified by the novel definition of myocardial infarction.

Methods

This cohort study included 1024 consecutive patients with non-ST segment elevation acute coronary syndrome classified into “unstable angina,” myocardial infarction according to the WHO definition (“WHO criteria”), and myocardial infarction additionally identified by the novel definition (“additional criteria”). All patients were treated with an early invasive strategy. The primary end point was all-cause mortality during follow-up of up to 36 months.

Results

During long-term follow-up (median 16 months, interquartile range 6-29 months), 67 deaths occurred. Kaplan-Meier analysis showed cumulative 3-year mortality rates of 5.6% in patients with “unstable angina,” 9.1% in patients identified by “WHO criteria,” and 17.5% in patients identified by “additional criteria” (P <.001). Cox regression analysis confirmed the “additional criteria” as a significant predictor of mortality (hazard ratio 3.1; 95% confidence interval, 1.9-5.0; P <.001).

Conclusions

The new definition of myocardial infarction based on cardiac troponin testing identifies a high-risk group of additional patients with acute coronary syndrome that is, therefore, appropriately classified as myocardial infarction. In fact, long-term mortality in “additional criteria” patients is higher than in “WHO criteria” patients.

Keywords: Coronary angiography, Coronary disease, Guidelines, Myocardial infarction, Prognosis, Unstable angina

 

 The authors declare that there are no conflicts of interest. Dr. Mueller was supported by research grants from the Swiss National Science Foundation, the Swiss Heart Foundation, and the Novartis Foundation. Design and conduct of the study as well as the preparation of the manuscript were not influenced by any of the sponsors.

PII: S0002-9343(08)00108-3

doi:10.1016/j.amjmed.2008.01.033

The American Journal of Medicine
Volume 121, Issue 5 , Pages 399-405, May 2008